Investments
Unquote Private Equity Podcast: Making an impact
Impact growth capital firm Lightrock's Pål Erik Sjåtil speaks to Unquote about impact investing and energy transition
Sponsors ponder ESG questions as EU Taxonomy spurs gas, nuclear funding flow hopes
Framework gives green light to deals in the sector but LP accountability could stymie potential investments
Q3 Barometer: M&A softens across entire PE spectrum
The latest Unquote Private Equity Barometer, produced in association with abrdn, is now available to download
3i plans over GBP1bn in exits with ‘better’ 2023 in sight
Positive turn to start by Q2; retailer Action valued at GBP 8.6bn, CEO said during results call
Platform boot camp: Buy-and-build holds fast in healthcare sector
Healthcare M&A has held up well in 2022 versus 2021, offering hope in a challenging market
EU’s pending foreign subsidies rules put PE deals in the spotlight
M&A from funds backed by Chinese and Middle Eastern investors likely to be the focus of enforcement
Q&A: BVCA’s VC committee chair on the current outlook for venture capital
Andrew Williamson discusses the UK VC market and investing in the current macroeconomic environment
Unigrains launches Italian unit with EUR 80m-100m investment plan
Milan-based operation will target agri-food businesses as sister fund FAI nears conclusion
BVCA Summit: PEs take long-term view to ride out uncertainty
Unquote reports on discussions around ESG, continuation funds and PE democratisation at last week’s event
Clearwater Multiples Heatmap: PE deals at record value in Q2 as macro pressure mounts
Sponsor transactions in Europe surged to an all-time high with TMT and the UK leading the way
Down but not out: UK PE market confident in spite of sterling, macro concerns
Sponsors prepare to weather the storm and seize opportunities emerging from the crisis
Q&A: Octopus Ventures on consumer investing in times of recession
Partner Rebecca Hunt on the VC’s approach to consumer tech deals and how household savings, pricing down will see businesses through the crisis
Q&A: Syz Capital's Marc Syz on PE fundraising and alternative asset allocations
Alternatives manager discusses topics including US interest in Europe, and the challenges ahead for large-cap buyout strategies
Second-hand: could continuation vehicles become ‘SPACs of 2022’?
As the pace of secondary fundraising and deals gains momentum, some challenges start to arise
Nordic Alpha to partner with business angels for greentech deal flow
Danish GP plans to raise money from 20-30 angels, giving them early access to its developing deal pipeline
C’est la rentrée: PEs line up French deals despite adverse market
Local economy managed to stay comparatively strong compared to sluggish global growth and inflationary pressures
Q2 Barometer: Value and volume bifurcation sets in
The latest Unquote Private Equity Barometer, produced in association with abrdn, is now available to download
HIG Europe's lower mid-cap strategy eyes succession and carve-out opportunities
Flexible remit allows EUR 2bn vehicle to invest through macroeconomic uncertainty
Buy now, realise later - sponsors go on spending spree amid exit lull
Mounting dry powder sees GPs turn to primary buyouts, P2Ps and carve-outs, although exit pressure remains
Pinova expects final close for Fund 3 before year-end
DACH industrial technology and IT investor has set a EUR 250m target for the vehicle
SwanCap plans October first close for Fund VI
German GP has a EUR 350m target for co-investment vehicle, which will follow the strategy of 2019-vintage predecessor
Sponsors brave the storm amid drop in financial services M&A
GP buyouts in the financial services space reached a two-year high in H1 2022 as rising financing costs and a brewing recession cloud the sector's M&A outlook
Optimism prevails as PEs expect step-up in deal-making – research
Third Bridge's Joshua Maxey speaks to Unquote about the findings of the Mid-market PE Forecast: 2022
Deft deployment, creative exits drive PE agenda into H2 2022
Take-privates, bolt-on opportunities and demand for resilient healthcare and technology assets offer hope for challenging second half of the year